CureVac has agreed a collaboration with Bayer to speed up production and distribution of its Covid-19 vaccine candidate CVnCOV, which began clinical trials in December...

Through a subsidiary, Shanghai, China-based WuXi Biologics (WuXi Bio) is acquiring Bayer’s biologics substance plant at Wuppertal, Germany, for €150 million ($183.3...

Bayer has taken another a step toward embracing cell therapy, this week signing a worldwide license agreement with Atara Biotherapeutics for next-generation, mesothelin...

In its biggest pharma acquisition since the 2006 takeover of Berlin-based women’s specialist Schering, Bayer plans to plunk down up to $4 billion for US biotech firm...

The California Supreme Court has declined to hear Bayer’s appeal of the first jury verdict against it in a series of cases brought by US plaintiffs charging that Monsanto...

In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a...

Bayer’s life science investment arm Leaps by Bayer and Singapore investor group Temasek have formed a new joint vertical farming company called Unfold. The companies did...

Bayer has begun construction on a new €50 million pharmaceutical facility in the Beijing Economic-Technological Development Area, aimed at boosting annual output in the...